Skip to main content
. 2003 Mar;47(3):1088–1095. doi: 10.1128/AAC.47.3.1088-1095.2003

TABLE 1.

Antibacterial effect measures for each strain of S. pneumoniae with each moxifloxacin dose simulation

Strain (MIC, mg/liter) Dose regimen
Viable counts (log CFU/ml)
AUBKC0-72 (log CFU/ml · h) T99.9 (h)
mg Interval between doses (h) n Δ24 Δ48 Δ72 Δmax
11622 (0.25) 400 24 3 −1.7 ± 1.1 −5.4 ± 0.8 −2.9 ± 0.2 −5.7 ± 0.5 220 ± 8 30 ± 6
400 12 3 −4.8 ± 0.5 −4.2 ± 1.0 −3.4 ± 1.2 −5.2 ± 0.5 150 ± 24 16 ± 7
800 24 3 −4.6 ± 1.5 −4.5 ± 1.2 −5.4 ± 0.2 −5.4 ± 0.2 124 ± 22 18 ± 12
12716 (1.0) 400 12 5 −3.3 ± 1.8 −5.7 ± 0.6 −6.2 ± 0.7 −6.2 ± 0.7 159 ± 44 19 ± 8
800 24 3 −1.9 ± 1.1 −6.3 ± 0.8 −6.0 ± 1.2 −6.7 ± 0.1 174 ± 28 29 ± 6
12648 (3.6) 400 24 3 +0.6 ± 0.6 +0.2 ± 0.4 +0.6 ± 0.6 −0.1 ± 0.1 456 ± 35 >72
400 12 3 +0.2 ± 0.7 +0.3 ± 0.2 +0.5 ± 0.4 −0.6 ± 0.4 440 ± 24 >72
800 24 3 −0.5 ± 0.5 +0.2 ± 0.2 −0.1 ± 0.3 −0.9 ± 0.1 425 ± 22 >72